Invion Ltd has released a press release.
Complete Regression of TNBC Tumours and Protective Immunity
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Capital Raising & co-development for Photosoft Technology
- Initial Proof-of-Concept results show INV043 to be effective
- App 4D and Financial Report for half year to 31 Dec 2020
- Business Update and Change to Board and Management
- Activities Report and Appendix 4C June 2020 Quarter
Later from Invion
- Further Information on Proof of Concept Pilot Study
- Capital Raising and expansion of Photosoft Territory
- Share Purchase Plan Offer Booklet & Application Form
- Prospectus
- Supplementary Prospectus
Follow Invion into a list and get an email when it puts out news.
Follow Invion